Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » Gov't & Regulatory

Gov't & Regulatory

Print

State FDA (SFDA), Ministry of Science and Technology (MOST), Minsitry of Health (MOH) and other China government agency policies and regulations and how they impact the industry...

Recent Articles

  China Adds 36 Drugs to NDRL Following Major Price Cuts
  Ninth ChinaBio® Partnering Forum Celebrates China Life Science "Sea Change"
  After US Request, China Bans Four Synthetic Opioids
  Sea Change: China Joins ICH -- International Harmonization of Drug Rules
  China's FDA Issues Proposals to Speed Drug Approvals, Improve IP
  China FDA Proposes New Rules to Speed Foreign Drug Approvals
  China to Announce New National Drug Reimbursement List
  New China Policy Puts Pressure on Drug Distributors to Consolidate
  China Fines Medtronic $17 Million for Setting Minimum Prices
  CFDA Addresses "80% of China Trials are Based on Fraudulent Data" Story
 
Login